The importance of educating patients about adverse effects of treatment
Impressive results from phase 3 RESONATE trial in CLL
Clinical evidence supporting rituximab
Won Seog Kim
Recent developments in the mutational landscape and molecular basis of AML
Empowering CLL patients: Do physicians need more communication skills training?